McKesson (NYSE:MCK) Updates FY 2025 Earnings Guidance

McKesson (NYSE:MCK - Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 31.250-32.050 for the period, compared to the consensus estimate of 31.020. The company issued revenue guidance of $355.3 billion-$361.5 billion, compared to the consensus revenue estimate of $340.6 billion.

Wall Street Analysts Forecast Growth

MCK has been the subject of several research reports. Morgan Stanley boosted their price objective on shares of McKesson from $522.00 to $548.00 and gave the company an overweight rating in a research note on Monday, April 15th. Barclays upped their price target on McKesson from $571.00 to $596.00 and gave the stock an overweight rating in a research note on Wednesday. Argus lifted their price objective on McKesson from $510.00 to $570.00 and gave the company a buy rating in a research note on Wednesday, April 10th. Mizuho increased their target price on shares of McKesson from $450.00 to $505.00 and gave the stock a neutral rating in a research report on Friday, February 9th. Finally, Evercore ISI lifted their price target on shares of McKesson from $590.00 to $600.00 and gave the company an outperform rating in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus target price of $569.86.

McKesson Trading Down 0.5 %

MCK stock traded down $2.53 during midday trading on Wednesday, hitting $543.22. 1,378,614 shares of the company's stock were exchanged, compared to its average volume of 713,234. The stock has a market capitalization of $71.38 billion, a price-to-earnings ratio of 24.49, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45. The firm has a 50 day moving average price of $531.17 and a 200-day moving average price of $493.81. McKesson has a 12-month low of $373.28 and a 12-month high of $566.01.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings data on Tuesday, May 7th. The company reported $6.18 earnings per share for the quarter, missing the consensus estimate of $6.34 by ($0.16). McKesson had a negative return on equity of 262.63% and a net margin of 0.99%. The company had revenue of $76.36 billion for the quarter, compared to analyst estimates of $79.32 billion. During the same period in the prior year, the business earned $7.19 earnings per share. McKesson's revenue was up 10.8% on a year-over-year basis. On average, sell-side analysts forecast that McKesson will post 27.59 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be given a dividend of $0.62 per share. This represents a $2.48 annualized dividend and a dividend yield of 0.46%. The ex-dividend date is Monday, June 3rd. McKesson's dividend payout ratio is currently 11.24%.

Insiders Place Their Bets

In other McKesson news, EVP Leann B. Smith sold 186 shares of the stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $496.00, for a total transaction of $92,256.00. Following the sale, the executive vice president now directly owns 1,511 shares of the company's stock, valued at $749,456. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other McKesson news, CEO Brian S. Tyler sold 3,473 shares of the business's stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the completion of the transaction, the chief executive officer now directly owns 43,445 shares of the company's stock, valued at approximately $22,789,074.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Leann B. Smith sold 186 shares of the business's stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the transaction, the executive vice president now owns 1,511 shares of the company's stock, valued at $749,456. The disclosure for this sale can be found here. 0.21% of the stock is currently owned by corporate insiders.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.